David J. Virley
Neurology and GI CEDD
GlaxoSmithKline Pharmaceuticals
Harlow
Essex
United Kingdom
Name/email consistency: high
- Developing therapeutics for the treatment of multiple sclerosis. Virley, D.J. NeuroRx (2005)
- A new primate model of focal stroke: endothelin-1-induced middle cerebral artery occlusion and reperfusion in the common marmoset. Virley, D., Hadingham, S.J., Roberts, J.C., Farnfield, B., Elliott, H., Whelan, G., Golder, J., David, C., Parsons, A.A., Hunter, A.J. J. Cereb. Blood Flow Metab. (2004)